Literature DB >> 6541304

Brainstem auditory evoked potential and blink reflex in multiple sclerosis.

R Kayamori, Q S Dickins, T Yamada, J Kimura.   

Abstract

Brainstem auditory evoked potential (BAEP) and blink reflex (BR) were abnormal in 40% and 26% of 130 patients with MS. Overall, BR was affected in 53% of patients with abnormal BAEP involving I-III and 41% of those involving III-V interval. In 23 patients with unilateral BR involvement, BAEP was affected ipsilaterally in 10, contralaterally in 0 and bilaterally in 8. In 12 patients with bilateral BR abnormalities, BAEP was involved unilaterally in 1 and bilaterally in 8. We conclude: (1) pontine lesions may prolong either I-III or III-V interwave latency of BAEP, and (2) unilateral abnormalities of BAEP tend to implicate the uncrossed auditory pathways.

Entities:  

Mesh:

Year:  1984        PMID: 6541304     DOI: 10.1212/wnl.34.10.1318

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Multiple sclerosis: diagnostic value of computerized tomography with delayed scanning after a double-dose of contrast medium in comparison with other diagnostic tests.

Authors:  C Weitze; G Hertel; W Brittner
Journal:  Neurosurg Rev       Date:  1988       Impact factor: 3.042

2.  Supratentorial multiple sclerosis lesions affect the blink reflex test.

Authors:  Efthimios H Mikropoulos; Afroditi A Papathanasiou; Georgios Hadjigeorgiou; Evangelia Tsironi; Alex Papadimitriou
Journal:  Open Neurol J       Date:  2010-09-08

3.  Electromyographic evaluation of blink reflex as a tool for early diagnosis of neurological dysfunction in patients of hypothyroidism.

Authors:  Gaurav Kakked; Nikita Bhatt; Jitendra Lakhani; Sanjay Prakash
Journal:  Ann Neurosci       Date:  2013-07

4.  Abnormal control of orbicularis oculi reflex excitability in multiple sclerosis.

Authors:  Christopher Cabib; Sara Llufriu; Eloy Martinez-Heras; Albert Saiz; Josep Valls-Solé
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.